UPDATE: JPMorgan Upgrades Gilead Sciences (GILD) to Overweight; 'Becoming Less Controversial with Increased Visibility'
Tweet Send to a Friend
(Updated - October 4, 2022 6:32 AM EDT)
JPMorgan analyst Chris Schott upgraded Gilead Sciences (NASDAQ: GILD) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Chris Schott upgraded Gilead Sciences (NASDAQ: GILD) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
